Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMontefiore Medical Center

About this trial

This multi-center retrospective cohort study aims to investigate the real-world outcomes of chronic subdural hematoma treated with MMAE, including clinical effectiveness, recurrence rates, and safety profile.

Eligibility criteria

Qualifiers

Consecutive adult patients (18 yrs. of age or older)

Disqualifiers

Endovascular embolization of middle meningeal artery using any other embolization material

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Montefiore Medical Center

Lead sponsor

Geisinger Clinic

Collaborator

Heidelberg University

Collaborator

Henri Mondor University Hospital

Collaborator

Ospedale Policlinico San Martino

Collaborator

Ospedale San Raffaele

Collaborator

Lehigh Valley Hospital

Collaborator

Mayo Clinic

Collaborator

Medical University of South Carolina

Collaborator

New York University

Collaborator

Oregon Health and Science University

Collaborator

Sisters of Mercy University Hospital

Collaborator

Unity Health Toronto

Collaborator

Sutter Health

Collaborator

University of Iowa

Collaborator

Thomas Jefferson University

Collaborator

University Health Network, Toronto

Collaborator

University Hospital, Bordeaux

Collaborator

University of Alabama at Birmingham

Collaborator

University of South Florida

Collaborator

University of Washington

Collaborator

Cornell University

Collaborator

Westchester Medical Center

Collaborator